Literature DB >> 2142150

Detection of provirus in an HTLV-II producer CD8+ T cell line by polymerase chain reaction combined with digoxigenin-ELISA method.

K Miyamoto1, N Tomita, Y Ohtsuki, K Kitajima.   

Abstract

A human T-cell leukemia virus type II (HTLV-II) producer cell line, designated HTLV-IIA, was established by cocultivation with leukocytes from an anti-human T-cell leukemia type I (HTLV-I) antibody-positive white male intravenous drug abuser and a healthy Japanese female. The cell line was examined for viral antigens by the indirect immunofluorescence method. The cytoplasm of over 80% of the cells was brilliantly stained. Cytogenetically, the cell line has a normal female karyotype. Electron microscopy of the HTLV-IIA disclosed many C-type retrovirus particles of mature, immature and non-cored types in the extracellular spaces. The surface markers of the transformed cells are CD2+, CD3+, CD4- and CD8+. To distinguish between HTLV-I and HTLV-II infection in the cell line, a method for detection of the HTLV-II provirus was developed by combining the polymerase chain reaction method with digoxigenin-enzyme-linked immunosorbent assay method.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2142150      PMCID: PMC5918052          DOI: 10.1111/j.1349-7006.1990.tb02567.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  19 in total

1.  High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans.

Authors:  H Lee; P Swanson; V S Shorty; J A Zack; J D Rosenblatt; I S Chen
Journal:  Science       Date:  1989-04-28       Impact factor: 47.728

2.  Integrated human T-cell leukemia virus II genome in CD8 + T cells from a patient with "atypical" hairy cell leukemia: evidence for distinct T and B cell lymphoproliferative disorders.

Authors:  J D Rosenblatt; J V Giorgi; D W Golde; J B Ezra; A Wu; C D Winberg; J Glaspy; W Wachsman; I S Chen
Journal:  Blood       Date:  1988-02       Impact factor: 22.113

3.  Detection of HIV1 DNA in infants and children by means of the polymerase chain reaction.

Authors:  F Laure; V Courgnaud; C Rouzioux; S Blanche; F Veber; M Burgard; C Jacomet; C Griscelli; C Brechot
Journal:  Lancet       Date:  1988-09-03       Impact factor: 79.321

4.  Non-radioactive hybridization probes prepared by the chemical labelling of DNA and RNA with a novel reagent, photobiotin.

Authors:  A C Forster; J L McInnes; D C Skingle; R H Symons
Journal:  Nucleic Acids Res       Date:  1985-02-11       Impact factor: 16.971

5.  Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene.

Authors:  K Shimotohno; Y Takahashi; N Shimizu; T Gojobori; D W Golde; I S Chen; M Miwa; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

6.  HTLV-I associated myelopathy, a new clinical entity.

Authors:  M Osame; K Usuku; S Izumo; N Ijichi; H Amitani; A Igata; M Matsumoto; M Tara
Journal:  Lancet       Date:  1986-05-03       Impact factor: 79.321

7.  Transformation of ATLA-negative leukocytes by blood components from anti-ATLA-positive donors in vitro.

Authors:  K Miyamoto; N Tomita; A Ishii; T Nishizaki; K Kitajima; T Tanaka; T Nakamura; S Watanabe; T Oda
Journal:  Int J Cancer       Date:  1984-06-15       Impact factor: 7.396

8.  A new agglutination test for serum antibodies to adult T-cell leukemia virus.

Authors:  M Ikeda; R Fujino; T Matsui; T Yoshida; H Komoda; J Imai
Journal:  Gan       Date:  1984-10

9.  The human T-cell leukemia/lymphoma virus associated with American adult T-cell leukemia/lymphoma.

Authors:  D W Blayney; E S Jaffe; W A Blattner; J Cossman; M Robert-Guroff; D L Longo; P A Bunn; R C Gallo
Journal:  Blood       Date:  1983-08       Impact factor: 22.113

10.  Human T-cell leukemia virus type II transforms normal human lymphocytes.

Authors:  I S Chen; S G Quan; D W Golde
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

View more
  7 in total

1.  Immunoelectron microscopic study of HTLV-II-producing cells with an anti-envelope gp46 monoclonal antibody.

Authors:  N Ohara; K Hayashi; K Miyamoto; K Takahashi; Y Ohtsuki; T Akagi
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

2.  Co-expression of CD4 and CD8 associated with elevated interleukin-4 in a cord T cell line derived by co-cultivating normal cord leukocytes and an HTLV-II-producing simian leukocyte cell line (Si-IIA).

Authors:  K Hayashi; N Ohara; K Fujiwara; H Aoki; H J Jeon; K Takahashi; N Tomita; K Miyamoto; T Akagi
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

3.  Detection of polymerase chain reaction-amplified human immunodeficiency virus type 1 proviral DNA with a digoxigenin-labeled RNA probe and an enzyme-linked immunoassay.

Authors:  Y He; F Coutlée; P Saint-Antoine; C Olivier; H Voyer; A Kessous-Elbaz
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

4.  Absence of HTLV-II co-infection in HTLV-I-associated myelopathy patients.

Authors:  K Miyamoto; T Nakamura; S Nagataki; N Tomita; K Kitajima
Journal:  Jpn J Cancer Res       Date:  1992-05

5.  Transformation of animal cells with human T-cell leukemia virus type II.

Authors:  K Miyamoto; N Tomita; K Hayashi; T Akagi
Journal:  Jpn J Cancer Res       Date:  1990-08

6.  Transformation of CD8+ T-cells producing a strong cytopathic effect on CD4+ T-cells through syncytium formation by HTLV-II.

Authors:  K Miyamoto; T Kamiya; J Minowada; N Tomita; K Kitajima
Journal:  Jpn J Cancer Res       Date:  1991-11

7.  HTLV-II non-integrated malignant lymphoma induction in Japanese white rabbits following intravenous inoculation of HTLV-II-infected simian leukocyte cell line (Si-IIA).

Authors:  K Hayashi; N Ohara; T R Koirala; H Ino; H L Chen; N Teramoto; E Kondo; T Yoshino; K Takahashi; M Yamada
Journal:  Jpn J Cancer Res       Date:  1994-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.